OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,474 JPY | +1.23% |
|
-2.81% | +21.22% |
| May. 27 | Olympus Enters into Put Option Agreement for Orthopedic Business Transfer | MT |
| May. 13 | Olympus' Attributable Profit Soars 69.1% in Fiscal 2024 | MT |
| Sales 2024 | 936B 5.95B | Sales 2025 * | 999B 6.35B | Capitalization | 2,883B 18.32B |
|---|---|---|---|---|---|
| Net income 2024 | 243B 1.54B | Net income 2025 * | 118B 747M | EV / Sales 2024 | 2.75 x |
| Net cash position 2024 * | 78.83B 501M | Net cash position 2025 * | 37.94B 241M | EV / Sales 2025 * | 2.85 x |
| P/E ratio 2024 |
11.1
x | P/E ratio 2025 * |
24.5
x | Employees | 32,844 |
| Yield 2024 |
0.81% | Yield 2025 * |
0.8% | Free-Float | 94.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | +1.23% | ||
| 1 week | -2.81% | ||
| 1 month | +12.41% | ||
| 3 months | +16.02% | ||
| 6 months | +14.20% | ||
| Current year | +21.22% |
1 week
2 396.50
2 544.50
1 month
2 190.002 603.00
Current year
1 935.502 603.00
1 year
1 782.002 603.00
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
758.753 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 19-05-31 |
Gary Pruden
BRD | Director/Board Member | 62 | 22-05-31 |
Yasushi Shingai
BRD | Director/Board Member | 68 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 32 M€ | +15.69% | ||
| 2.11% | 10 M€ | +15.87% | - | |
| 1.55% | 240 M€ | +17.47% | ||
| 1.23% | 28,258 M€ | +15.99% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 2,474 | +1.23% | 7,369,400 |
| 24-05-30 | 2,444 | -0.73% | 7,271,000 |
| 24-05-29 | 2,462 | -0.73% | 3,357,000 |
| 24-05-28 | 2,480 | -1.94% | 3,261,100 |
| 24-05-27 | 2,528 | -0.65% | 2,360,800 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-08-06
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
2,474
JPY
Average target price
2,641
JPY
Spread / Average Target
+6.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.22% | 18.34B | |
| +7.01% | 217B | |
| +11.01% | 190B | |
| +19.20% | 143B | |
| +30.79% | 111B | |
| +1.48% | 64.59B | |
| +13.95% | 52.36B | |
| -0.16% | 48.45B | |
| -6.20% | 38.03B | |
| +0.91% | 35.61B |
- Stock Market
- Equities
- 7733 Stock
